What is Varex Imaging Corp's earnings per share (EPS)?

Varex Imaging Corp (VREX) reported diluted earnings per share of $-1.70 for fiscal year 2025. This represents a -41.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Varex Imaging Corp Financials

VREX

Source SEC Filings (10-K/10-Q) Updated Feb 10, 2026 Currency USD FYE October

This page shows Varex Imaging Corp (VREX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 41/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Varex Imaging Corp has an operating margin of -3.3%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 15/100, suggesting thin profitability after operating expenses. This is down from 4.0% the prior year.

Growth

Varex Imaging Corp's revenue grew a modest 4.1% year-over-year to $844.6M. This slow but positive growth earns a score of 40/100.

Leverage

Varex Imaging Corp carries a low D/E ratio of 0.77, meaning only $0.77 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 86/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.89, Varex Imaging Corp holds $3.89 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 76/100.

Cash Flow

Varex Imaging Corp has a free cash flow margin of 2.2%, earning a moderate score of 31/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Varex Imaging Corp generates a -14.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -9.2% the prior year.

Piotroski F-Score Neutral

5/9

Varex Imaging Corp passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-0.59x

For every $1 of reported earnings, Varex Imaging Corp generates $-0.59 in operating cash flow ($41.7M OCF vs -$70.3M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-0.8x

Varex Imaging Corp earns $-0.8 in operating income for every $1 of interest expense (-$27.8M vs $35.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$844.6M

YoY+4.1%

5Y CAGR+2.7%

10Y CAGR+2.9%

Varex Imaging Corp generated $844.6M in revenue in fiscal year 2025. This represents an increase of 4.1% from the prior year.

EBITDA

$400K

YoY-99.4%

5Y CAGR-41.4%

10Y CAGR-44.3%

Varex Imaging Corp's EBITDA was $400K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 99.4% from the prior year.

Net Income

-$70.3M

YoY-44.1%

Varex Imaging Corp reported -$70.3M in net income in fiscal year 2025. This represents a decrease of 44.1% from the prior year.

EPS (Diluted)

$-1.70

YoY-41.7%

Varex Imaging Corp earned $-1.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 41.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$18.8M

YoY-7.8%

10Y CAGR-9.5%

Varex Imaging Corp generated $18.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 7.8% from the prior year.

Cash & Debt

$119.5M

YoY-29.2%

5Y CAGR+2.5%

10Y CAGR+13.2%

Varex Imaging Corp held $119.5M in cash against $366.2M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

42M

YoY+1.9%

5Y CAGR+1.3%

Varex Imaging Corp had 42M shares outstanding in fiscal year 2025. This represents an increase of 1.9% from the prior year.

Margins & Returns

Gross Margin

34.4%

YoY+2.7pp

5Y CAGR+8.6pp

10Y CAGR-5.2pp

Varex Imaging Corp's gross margin was 34.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.7 percentage points from the prior year.

Operating Margin

-3.3%

YoY-7.3pp

5Y CAGR+1.3pp

10Y CAGR-23.4pp

Varex Imaging Corp's operating margin was -3.3% in fiscal year 2025, reflecting core business profitability. This is down 7.3 percentage points from the prior year.

Net Margin

-8.3%

YoY-2.3pp

5Y CAGR-0.5pp

10Y CAGR-21.0pp

Varex Imaging Corp's net profit margin was -8.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.3 percentage points from the prior year.

Return on Equity

-14.7%

YoY-5.5pp

5Y CAGR-1.9pp

Varex Imaging Corp's ROE was -14.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.5 percentage points from the prior year.

Capital Allocation

R&D Spending

$91.1M

YoY+4.7%

5Y CAGR+2.9%

10Y CAGR+6.1%

Varex Imaging Corp invested $91.1M in research and development in fiscal year 2025. This represents an increase of 4.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$22.9M

YoY-14.9%

5Y CAGR-0.5%

10Y CAGR-4.0%

Varex Imaging Corp invested $22.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 14.9% from the prior year.

VREX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$844.6M+4.1%	$811.0M-9.2%	$893.4M+4.0%	$859.4M+5.0%	$818.1M+10.8%	$738.3M
Cost of Revenue	$554.1M0.0%	$554.1M-8.1%	$603.1M+4.7%	$575.9M+5.4%	$546.6M-0.3%	$548.1M
Gross Profit	$290.5M+13.1%	$256.9M-11.5%	$290.3M+2.4%	$283.5M+4.4%	$271.5M+42.7%	$190.2M
R&D Expenses	$91.1M+4.7%	$87.0M+2.6%	$84.8M+10.1%	$77.0M+7.1%	$71.9M-8.9%	$78.9M
SG&A Expenses	$133.3M-3.3%	$137.8M+7.3%	$128.4M+8.5%	$118.3M-5.7%	$125.5M-11.7%	$142.2M
Operating Income	-$27.8M-186.6%	$32.1M-58.4%	$77.1M-12.6%	$88.2M+19.0%	$74.1M+319.9%	-$33.7M
Interest Expense	$35.5M+17.5%	$30.2M+3.1%	$29.3M-26.4%	$39.8M-5.5%	$42.1M+34.1%	$31.4M
Income Tax	$10.7M-79.9%	$53.3M+421.1%	-$16.6M-221.2%	$13.7M+28.0%	$10.7M+170.4%	-$15.2M
Net Income	-$70.3M-44.1%	-$48.8M-203.0%	$47.4M+56.4%	$30.3M+74.1%	$17.4M+130.1%	-$57.9M
EPS (Diluted)	$-1.70-41.7%	$-1.20-212.1%	$1.07+46.6%	$0.73+69.8%	$0.43+128.9%	$-1.49

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$210-100.0%	$209.6M-8.4%	$228.9M+12.8%	$203.0M-4.7%	$212.9M+6.6%	$199.8M-2.9%	$205.7M-1.6%	$209.1M
Cost of Revenue	$140-100.0%	$139.8M-7.5%	$151.1M+11.5%	$135.5M-0.5%	$136.2M+3.7%	$131.3M-5.3%	$138.6M-2.5%	$142.2M
Gross Profit	$70-100.0%	$69.8M-10.3%	$77.8M+15.3%	$67.5M-12.0%	$76.7M+12.0%	$68.5M+2.1%	$67.1M+0.3%	$66.9M
R&D Expenses	$22-100.0%	$21.7M-10.3%	$24.2M+13.1%	$21.4M-2.7%	$22.0M-6.4%	$23.5M+7.3%	$21.9M-0.5%	$22.0M
SG&A Expenses	$33-100.0%	$32.7M-3.8%	$34.0M+3.3%	$32.9M+0.9%	$32.6M-3.6%	$33.8M-1.5%	$34.3M-3.7%	$35.6M
Operating Income	$15-100.0%	$15.4M-21.4%	$19.6M+124.3%	-$80.7M-465.2%	$22.1M+97.3%	$11.2M+2.8%	$10.9M+17.2%	$9.3M
Interest Expense	$8-100.0%	$7.9M0.0%	$7.9M-16.0%	$9.4M-7.8%	$10.2M+27.5%	$8.0M+5.3%	$7.6M+2.7%	$7.4M
Income Tax	$1-100.0%	$1.4M-26.3%	$1.9M-24.0%	$2.5M-32.4%	$3.7M+42.3%	$2.6M-95.1%	$53.5M+7742.9%	-$700K
Net Income	$2-100.0%	$2.3M-81.1%	$12.2M+113.7%	-$89.1M-1391.3%	$6.9M+2400.0%	-$300K+99.4%	-$51.1M-3750.0%	$1.4M
EPS (Diluted)	$0.050.0%	$0.05	N/A	$-2.15-1364.7%	$0.17+1800.0%	$-0.01	N/A	$0.03

VREX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.1B-9.5%	$1.2B-2.9%	$1.2B+5.5%	$1.2B+4.0%	$1.1B+0.2%	$1.1B
Current Assets	$633.6M-2.5%	$649.9M-1.3%	$658.3M+7.9%	$609.9M+9.3%	$557.9M+6.8%	$522.6M
Cash & Equivalents	$119.5M-29.2%	$168.7M+10.6%	$152.6M+70.7%	$89.4M-43.3%	$157.8M+49.6%	$105.5M
Inventory	$328.0M+23.9%	$264.8M-4.6%	$277.5M-8.5%	$303.2M+22.5%	$247.6M-8.2%	$269.8M
Accounts Receivable	$146.5M-7.1%	$157.7M-3.6%	$163.6M-5.6%	$173.3M+36.3%	$127.1M+5.0%	$121.0M
Goodwill	$198.4M-31.8%	$291.0M+0.9%	$288.5M+1.4%	$284.5M-2.3%	$291.2M-1.4%	$295.3M
Total Liabilities	$607.2M-9.4%	$670.4M+0.3%	$668.6M+4.8%	$637.7M+0.8%	$632.9M-5.9%	$672.7M
Current Liabilities	$163.0M-16.8%	$195.9M+20.3%	$162.8M-6.0%	$173.1M+15.5%	$149.9M-1.7%	$152.5M
Long-Term Debt	$366.2M-7.8%	$397.1M-10.0%	$441.1M+7.0%	$412.3M-4.9%	$433.7M-5.2%	$457.5M
Total Equity	$476.9M-9.9%	$529.1M-6.8%	$567.7M+6.4%	$533.4M+8.2%	$492.8M+9.5%	$450.2M
Retained Earnings	-$3.6M-105.6%	$64.4M-45.5%	$118.1M+85.1%	$63.8M+82.8%	$34.9M+259.8%	$9.7M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1K-100.0%	$1.1B-0.8%	$1.1B+3.2%	$1.1B-20.9%	$1.4B+1.9%	$1.3B+9.8%	$1.2B-3.1%	$1.3B
Current Assets	$634-100.0%	$633.6M-1.3%	$641.8M+3.6%	$619.5M-9.4%	$683.8M+4.1%	$656.9M+1.1%	$649.9M+0.1%	$649.3M
Cash & Equivalents	$120-100.0%	$119.5M-17.6%	$145.0M+6.3%	$136.4M-33.5%	$205.1M+16.5%	$176.0M+4.3%	$168.7M+7.9%	$156.4M
Inventory	$328-100.0%	$328.0M+9.6%	$299.4M+0.2%	$298.7M+4.9%	$284.7M+1.7%	$279.9M+5.7%	$264.8M-6.0%	$281.7M
Accounts Receivable	$147-100.0%	$146.5M-6.4%	$156.6M+14.3%	$137.0M-6.0%	$145.7M+5.5%	$138.1M-12.4%	$157.7M+3.8%	$152.0M
Goodwill	$198-100.0%	$198.4M0.0%	$198.4M-0.1%	$198.5M-31.6%	$290.3M+1.1%	$287.2M-1.3%	$291.0M+0.7%	$288.9M
Total Liabilities	$607-100.0%	$607.2M-2.2%	$620.8M+2.8%	$603.9M-23.9%	$793.7M+2.0%	$778.0M+16.1%	$670.4M+2.0%	$657.4M
Current Liabilities	$163-100.0%	$163.0M-12.9%	$187.2M+5.9%	$176.7M+4.7%	$168.8M+12.2%	$150.5M-23.2%	$195.9M+0.7%	$194.6M
Long-Term Debt	$366-100.0%	$366.2M+0.1%	$366.0M0.0%	$366.0M-35.3%	$565.8M0.0%	$565.6M+42.4%	$397.1M+0.1%	$396.9M
Total Equity	$477-100.0%	$476.9M+0.9%	$472.6M+3.8%	$455.3M-17.2%	$549.7M+1.8%	$540.2M+2.1%	$529.1M-9.0%	$581.2M
Retained Earnings	$4+100.0%	-$3.6M+39.0%	-$5.9M+67.4%	-$18.1M-123.5%	$77.0M+9.8%	$70.1M+8.9%	$64.4M-46.5%	$120.4M

VREX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$41.7M-11.8%	$47.3M-56.4%	$108.4M+541.4%	$16.9M-81.7%	$92.6M+601.5%	$13.2M
Capital Expenditures	$22.9M-14.9%	$26.9M+30.0%	$20.7M-2.8%	$21.3M+41.1%	$15.1M-35.7%	$23.5M
Free Cash Flow	$18.8M-7.8%	$20.4M-76.7%	$87.7M+2093.2%	-$4.4M-105.7%	$77.5M+852.4%	-$10.3M
Investing Cash Flow	$10.3M+137.5%	-$27.5M+38.8%	-$44.9M+7.2%	-$48.4M-198.8%	-$16.2M+39.8%	-$26.9M
Financing Cash Flow	-$75.9M-2200.0%	-$3.3M-1550.0%	-$200K+99.2%	-$23.8M+26.3%	-$32.3M-138.6%	$83.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$16+100.0%	-$16.1M-303.8%	$7.9M+2.6%	$7.7M-53.6%	$16.6M+74.7%	$9.5M-63.3%	$25.9M+223.7%	$8.0M
Capital Expenditures	$11-100.0%	$10.7M+91.1%	$5.6M-11.1%	$6.3M-7.4%	$6.8M+61.9%	$4.2M-30.0%	$6.0M+27.7%	$4.7M
Free Cash Flow	$5+100.0%	-$26.8M-1265.2%	$2.3M+64.3%	$1.4M-85.7%	$9.8M+84.9%	$5.3M-73.4%	$19.9M+503.0%	$3.3M
Investing Cash Flow	$8+100.0%	-$7.7M-1000.0%	-$700K0.0%	-$700K-104.8%	$14.7M+590.0%	-$3.0M+78.6%	-$14.0M-281.8%	$7.7M
Financing Cash Flow	$2+100.0%	-$1.6M-245.5%	$1.1M+100.5%	-$201.2M-28642.9%	-$700K-100.6%	$124.9M+15512.5%	$800K+172.7%	-$1.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

VREX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	34.4%+2.7pp	31.7%-0.8pp	32.5%-0.5pp	33.0%-0.2pp	33.2%+7.4pp	25.8%
Operating Margin	-3.3%-7.3pp	4.0%-4.7pp	8.6%-1.6pp	10.3%+1.2pp	9.1%+13.6pp	-4.6%
Net Margin	-8.3%-2.3pp	-6.0%-11.3pp	5.3%+1.8pp	3.5%+1.4pp	2.1%+10.0pp	-7.8%
Return on Equity	-14.7%-5.5pp	-9.2%-17.6pp	8.3%+2.7pp	5.7%+2.2pp	3.5%+16.4pp	-12.9%
Return on Assets	-6.4%-2.4pp	-4.0%-7.8pp	3.8%+1.2pp	2.6%+1.0pp	1.5%+6.6pp	-5.1%
Current Ratio	3.89+0.6	3.32-0.7	4.04+0.5	3.52-0.2	3.72+0.3	3.43
Debt-to-Equity	0.77+0.0	0.75-0.0	0.780.0	0.77-0.1	0.88-0.1	1.02
FCF Margin	2.2%-0.3pp	2.5%-7.3pp	9.8%+10.3pp	-0.5%-10.0pp	9.5%+10.9pp	-1.4%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	33.3%0.0pp	33.3%-0.7pp	34.0%+0.7pp	33.3%-2.8pp	36.0%+1.8pp	34.3%+1.7pp	32.6%+0.6pp	32.0%
Operating Margin	7.3%0.0pp	7.3%-1.2pp	8.6%+48.3pp	-39.8%-50.1pp	10.4%+4.8pp	5.6%+0.3pp	5.3%+0.9pp	4.5%
Net Margin	1.1%0.0pp	1.1%-4.2pp	5.3%+49.2pp	-43.9%-47.1pp	3.2%+3.4pp	-0.1%+24.7pp	-24.8%-25.5pp	0.7%
Return on Equity	0.5%0.0pp	0.5%-2.1pp	2.6%+22.1pp	-19.6%-20.8pp	1.3%+1.3pp	-0.1%+9.6pp	-9.7%-9.9pp	0.2%
Return on Assets	0.2%0.0pp	0.2%-0.9pp	1.1%+9.4pp	-8.3%-8.8pp	0.5%+0.5pp	-0.0%+4.2pp	-4.2%-4.3pp	0.1%
Current Ratio	3.890.0	3.89+0.5	3.43-0.1	3.51-0.5	4.05-0.3	4.36+1.0	3.32-0.0	3.34
Debt-to-Equity	0.770.0	0.770.0	0.77-0.0	0.80-0.2	1.03-0.0	1.05+0.3	0.75+0.1	0.68
FCF Margin	2.6%+15.4pp	-12.8%-13.8pp	1.0%+0.3pp	0.7%-3.9pp	4.6%+1.9pp	2.6%-7.0pp	9.7%+8.1pp	1.6%

Similar Companies

Surmodics Inc SRDX

$614.5M

Cytek Biosciences, Inc. CTKB

$582.3M

Bioventus Inc. BVS

$604.3M

Orthopedia KIDS

$406.0M

ZIMVIE INC ZIMV

$535.7M

Frequently Asked Questions

What is Varex Imaging Corp's annual revenue?

Varex Imaging Corp (VREX) reported $844.6M in total revenue for fiscal year 2025. This represents a 4.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Varex Imaging Corp's revenue growing?

Varex Imaging Corp (VREX) revenue grew by 4.1% year-over-year, from $811.0M to $844.6M in fiscal year 2025.

Is Varex Imaging Corp profitable?

No, Varex Imaging Corp (VREX) reported a net income of -$70.3M in fiscal year 2025, with a net profit margin of -8.3%.

What is Varex Imaging Corp's EBITDA?

Varex Imaging Corp (VREX) had EBITDA of $400K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Varex Imaging Corp have?

As of fiscal year 2025, Varex Imaging Corp (VREX) had $119.5M in cash and equivalents against $366.2M in long-term debt.

What is Varex Imaging Corp's gross margin?

Varex Imaging Corp (VREX) had a gross margin of 34.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Varex Imaging Corp's operating margin?

Varex Imaging Corp (VREX) had an operating margin of -3.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Varex Imaging Corp's net profit margin?

Varex Imaging Corp (VREX) had a net profit margin of -8.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Varex Imaging Corp's return on equity (ROE)?

Varex Imaging Corp (VREX) has a return on equity of -14.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Varex Imaging Corp's free cash flow?

Varex Imaging Corp (VREX) generated $18.8M in free cash flow during fiscal year 2025. This represents a -7.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Varex Imaging Corp's operating cash flow?

Varex Imaging Corp (VREX) generated $41.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Varex Imaging Corp's total assets?

Varex Imaging Corp (VREX) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Varex Imaging Corp's capital expenditures?

Varex Imaging Corp (VREX) invested $22.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Varex Imaging Corp spend on research and development?

Varex Imaging Corp (VREX) invested $91.1M in research and development during fiscal year 2025.

How many shares does Varex Imaging Corp have outstanding?

Varex Imaging Corp (VREX) had 42M shares outstanding as of fiscal year 2025.

What is Varex Imaging Corp's current ratio?

Varex Imaging Corp (VREX) had a current ratio of 3.89 as of fiscal year 2025, which is generally considered healthy.

What is Varex Imaging Corp's debt-to-equity ratio?

Varex Imaging Corp (VREX) had a debt-to-equity ratio of 0.77 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Varex Imaging Corp's return on assets (ROA)?

Varex Imaging Corp (VREX) had a return on assets of -6.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Varex Imaging Corp's Piotroski F-Score?

Varex Imaging Corp (VREX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Varex Imaging Corp's earnings high quality?

Varex Imaging Corp (VREX) has an earnings quality ratio of -0.59x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Varex Imaging Corp cover its interest payments?

Varex Imaging Corp (VREX) has an interest coverage ratio of -0.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Varex Imaging Corp?

Varex Imaging Corp (VREX) scores 41 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.